The results showed that three genes (TXNIP, CD44, and ENTPD1) were significantly upregulated in peripheral blood from high-risk PBC patients, while the expression of PDGFRB was not statistically different between the two groups (Fig. 8A–D). The gene discussed is CD44; the disease is primary biliary cholangitis.